Free shipping on all orders over $ 500

Cotosudil

Cat. No. M21675

All AbMole products are for research use only, cannot be used for human consumption.

Cotosudil Structure
Size Price Availability Quantity
5mg USD 348  USD348 In stock
10mg USD 545  USD545 In stock
25mg USD 1050  USD1050 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Cotosudil is a ROCK kinase inhibitor. Cotosudil can be used for glaucoma or ocular hypertension research.

Chemical Information
Molecular Weight 319.42
Formula C16H21N3O2S
CAS Number 1258833-31-6
Solubility (25°C) DMSO ≥ 30 mg/mL (May need ultrasonic and warming)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] N A Locket. Aust N Z J Ophthalmol. Problems of deep foveas

Related ROCK Products
OXA-06 hydrochloride 

OXA-06 hydrochloride is an ATP-competitive ROCK inhibitor that blocks anchorage-dependent growth and invasion of non-small cell lung cancer cell lines.

Y-33075 hydrochloride

Y-33075 hydrochloride (Y-39983) is a selective ROCK inhibitor derived from Y-27632, and is more potent than Y-27632, with an IC50 of 3.6 nM.

SR-3677 dihydrochloride 

SR-3677 dihydrochloride is a potent and selective ROCK-I and ROCK-II inhibitor with an IC50 values of 56 nM and 3 nM.

Akt/ROCK-IN-1

Akt/ROCK-IN-1 (B12) is a dual inhibitor for Akt and ROCK, with the IC50s of 0.023 nM and 1.47 nM, respectively.

Scaff10-8

Scaff10-8, bound to RhoA, inhibits the AKAP-Lbc-mediated RhoA activation.

  Catalog
Abmole Inhibitor Catalog




Keywords: Cotosudil supplier, ROCK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.